Trajan Group Holdings: Record Revenue and Strategic Growth in FY25

Trajan Group Holdings Limited (ASX: TRJ), a global leader in analytical and life sciences products, reported record financial performance for FY25. The company achieved net revenue of AU$166.5 million, surpassing its guidance and marking a 7.4% year-on-year growth despite an AU$3.9 million loss from a discontinued biotech syringe line. Group nEBITDA rose 26.6% to AU$15.5 million, though slightly below guidance, impacted by foreign exchange fluctuations, delayed microsampling shipments, and a shift toward price-sensitive emerging markets.

The company strengthened its balance sheet with cash rising to AU$11.9 million and net debt reducing to AU$29.6 million, lowering leverage to 1.9x. Trajan’s diversified portfolio, global footprint across seven manufacturing sites, and focus on decentralized, personalized healthcare solutions position it for sustained margin expansion and EBITDA growth in FY26. Full-year results will be released on 28 August 2025

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com